FTXH
First Trust Nasdaq Pharmaceuticals ETF
1W: +2.6%
1M: +5.1%
3M: +16.0%
YTD: +17.8%
1Y: +45.2%
3Y: +53.2%
5Y: +63.8%
$39.69
+0.64 (+1.63%)
Weekly Expected Move ±3.0%
$37
$38
$39
$40
$41
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$38M
Holdings50
Top 10 Wt0.0%
Volume630,721
Avg Volume549,022
Beta0.45
Portfolio Fundamentals
P/E34.6
P/B8.7
Div Yield0.62%
ROE24.5%
% Profitable60%
Inception2016-09-22
Sector Allocation
Healthcare
0.0%
Other
0.0%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Guardant Health, Inc. | GH | 0.00% | $5.8M | 1,906 |
| 2 | Elanco Animal Health Incorporated | ELAN | 0.00% | $6.6M | 12,871 |
| 3 | TG Therapeutics, Inc. | TGTX | 0.00% | $6.8M | 5,948 |
| 4 | Twist Bioscience Corporation | TWST | 0.00% | $7.1M | 3,815 |
| 5 | Travere Therapeutics, Inc. | TVTX | 0.00% | $7.1M | 6,008 |
| 6 | 10X Genomics, Inc. (Class A) | TXG | 0.00% | $7.4M | 7,765 |
| 7 | Spyre Therapeutics, Inc. | SYRE | 0.00% | $8.7M | 4,162 |
| 8 | BioMarin Pharmaceutical Inc. | BMRN | 0.00% | $9.0M | 7,443 |
| 9 | Halozyme Therapeutics, Inc. | HALO | 0.00% | $9.9M | 5,896 |
| 10 | PTC Therapeutics, Inc. | PTCT | 0.00% | $10.1M | 6,420 |